Medicare “Inherent Reasonableness” Standard Should Be Clarified, BIO Says
Executive Summary
The Centers for Medicare & Medicaid Services should clarify its guidelines for applying the "inherent reasonableness" standard to coverage decisions, the Biotechnology Industry Organization says